{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1390564238083172608.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.3805/eands.11.1"}},{"identifier":{"@type":"URI","@value":"https://www.jstage.jst.go.jp/article/eands/11/1/11_1/_pdf"}},{"identifier":{"@type":"NAID","@value":"130007631571"}},{"identifier":{"@type":"URI","@value":"https://search.jamas.or.jp/link/ui/2020003539"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@language":"en","@value":"Effects of antiepileptic monotherapy on hematological and biochemical parameters"}],"dc:language":"en","description":[{"type":"abstract","notation":[{"@language":"en","@value":"<p><b>Purpose</b>: Severe cytopenia and liver dysfunction are characterized as antiepileptic drug (AED) adverse effects dependent upon an idiosyncrasy. However, in clinical practice, we often find hemato-logical and biochemical changes during AED treatment with causes other than an idiosyncrasy. This study aims to investigate the effect of antiepileptic monotherapy on hematological and biochemical parameters.</p><p><b>Methods</b>: We retrospectively recruited 480 patients untreated with AED at baseline. Changes in hematological and biochemical parameters before and after initiation of medication were investigated, and correlation with plasma concentrations of AED was analyzed.</p><p><b>Results</b>: Sixty-six of 480 patients treated with carbamazepine (CBZ: n = 27), sodium valproate (VPA: n = 19) or levetiracetam (LEV: n = 20) monotherapy were eventually selected for analysis. After CBZ treatment, decreased white blood cell (WBC) count and increased gamma-glutamyltransferase (GGT) and alkaline phosphatase (ALP) activities were recorded at high frequencies. Decreased WBC count tended to correlate with elevated serum CBZ level. Elevated GGT activity was observed in all patients treated with CBZ. In patients treated with VPA, platelet (PLT) counts decreased. In patients treated with LEV, there were no significant differences in the measured parameters before and after medication.</p><p><b>Discussion</b>: We considered that the reduction in WBC count might be dose-dependently related to AEDs. Elevated GGT activity was observed in all patients treated with CBZ, but the average increase in GGT activity was 35.19 ± 33.08 U/L. In patients undergoing VPA treatment, decreased PLT counts were also observed at high frequency. Thus, hematological and biochemical parameters should be closely monitored in patients receiving AED, especially in patients treated with high doses of AEDs.</p>"}],"abstractLicenseFlag":"disallow"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1410564238083172613","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000402263499"}],"foaf:name":[{"@language":"en","@value":"Ohta Kaseya"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Onda-Daini Hospital"}]},{"@id":"https://cir.nii.ac.jp/crid/1410564238083172609","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000402263500"}],"foaf:name":[{"@language":"en","@value":"Sumi Yuki"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Respiratory and Nervous System Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University"}]},{"@id":"https://cir.nii.ac.jp/crid/1410564238083172612","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000402263498"}],"foaf:name":[{"@language":"en","@value":"Akaza Miho"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Respiratory and Nervous System Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University"}]},{"@id":"https://cir.nii.ac.jp/crid/1410564238083172608","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000402263502"}],"foaf:name":[{"@language":"en","@value":"Yanagisawa Eriko"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Medical Technology, School of Health Care Sciences, Faculty of Medicine, Tokyo Medical and Dental University"}]},{"@id":"https://cir.nii.ac.jp/crid/1410564238083172615","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000402263496"}],"foaf:name":[{"@language":"en","@value":"Yoshimura Yuri"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University"}]},{"@id":"https://cir.nii.ac.jp/crid/1410564238083172614","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000402263497"}],"foaf:name":[{"@language":"en","@value":"Hara Keiko"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Hara Clinic"},{"@language":"en","@value":"Department of Respiratory and Nervous System Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University"}]},{"@id":"https://cir.nii.ac.jp/crid/1410564238083172610","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000402263501"}],"foaf:name":[{"@language":"en","@value":"Inaji Motoki"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University"}]},{"@id":"https://cir.nii.ac.jp/crid/1420845751161472256","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"40211560"},{"@type":"NRID","@value":"1000040211560"},{"@type":"NRID","@value":"9000408585886"},{"@type":"NRID","@value":"9000391593289"},{"@type":"NRID","@value":"9000408768785"},{"@type":"NRID","@value":"9000397648221"},{"@type":"NRID","@value":"9000258743831"},{"@type":"NRID","@value":"9000398819917"},{"@type":"NRID","@value":"9000003590827"},{"@type":"NRID","@value":"9000382051289"},{"@type":"NRID","@value":"9000414350100"},{"@type":"NRID","@value":"9000359885244"},{"@type":"NRID","@value":"9000397648182"},{"@type":"NRID","@value":"9000411212143"},{"@type":"NRID","@value":"9000403403864"},{"@type":"NRID","@value":"9000002127333"},{"@type":"NRID","@value":"9000398130558"},{"@type":"NRID","@value":"9000399221793"},{"@type":"NRID","@value":"9000001372110"},{"@type":"NRID","@value":"9000345374399"},{"@type":"NRID","@value":"9000402263503"},{"@type":"NRID","@value":"9000405104846"},{"@type":"NRID","@value":"9000405645310"},{"@type":"NRID","@value":"9000325830012"},{"@type":"NRID","@value":"9000396169332"},{"@type":"NRID","@value":"9000404645142"},{"@type":"NRID","@value":"9000000966097"},{"@type":"NRID","@value":"9000018707272"},{"@type":"NRID","@value":"9000399510671"},{"@type":"NRID","@value":"9000410469466"},{"@type":"NRID","@value":"9000242076903"},{"@type":"NRID","@value":"9000412295877"},{"@type":"NRID","@value":"9000409494993"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/read0068474"}],"foaf:name":[{"@language":"en","@value":"Maehara Taketoshi"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University"}]}],"publication":{"publicationIdentifier":[{"@type":"EISSN","@value":"18825567"}],"prism:publicationName":[{"@language":"en","@value":"Epilepsy & Seizure"},{"@language":"en","@value":"E&S"}],"dc:publisher":[{"@language":"en","@value":"JAPAN EPILEPSY SOCIETY"},{"@language":"ja","@value":"一般社団法人 日本てんかん学会"}],"prism:publicationDate":"2019","prism:volume":"11","prism:number":"1","prism:startingPage":"1","prism:endingPage":"13"},"reviewed":"false","url":[{"@id":"https://www.jstage.jst.go.jp/article/eands/11/1/11_1/_pdf"},{"@id":"https://search.jamas.or.jp/link/ui/2020003539"}],"availableAt":"2019","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Antiepileptic%20drug","dc:title":"Antiepileptic drug"},{"@id":"https://cir.nii.ac.jp/all?q=Hematological","dc:title":"Hematological"},{"@id":"https://cir.nii.ac.jp/all?q=Biochemical","dc:title":"Biochemical"},{"@id":"https://cir.nii.ac.jp/all?q=effect","dc:title":"effect"},{"@id":"https://cir.nii.ac.jp/all?q=Monotherapy","dc:title":"Monotherapy"},{"@id":"https://cir.nii.ac.jp/all?q=Leukocyte%20reduction","dc:title":"Leukocyte reduction"}],"project":[{"@id":"https://cir.nii.ac.jp/crid/1040282256893364352","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"16K10782"},{"@type":"JGN","@value":"JP16K10782"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-16K10782/"}],"notation":[{"@language":"ja","@value":"てんかん原性バイオマーカーとしてのレッドスパイクの検出と臨床応用の研究"},{"@language":"en","@value":"Study of detection and clinical application of red spikes as biomarker for epileptogenic areas"}]}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360292618647571968","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"ILAE Treatment Guidelines: Evidence‐based Analysis of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and Syndromes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574094547764992","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Hepatic enzymes' level during chronic use of anticonvulsant drugs"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855569771775488","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Early effect of sodium valproate and carbamazepine monotherapy on homocysteine metabolism in children with epilepsy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855571271556992","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Hematologic Manifestations of Long‐Term Valproate Therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855571379877888","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Hematologic Toxicity of Sodium Valproate"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137044598067456","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Alkaline phosphatase and its isoenzyme activity for the evaluation of bone metabolism in children receiving anticonvulsant monotherapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137045619770496","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Neutropenia Secondary to Exposure to Levetiracetam"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418518538907264","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Hepatotoxicity associated with antiepileptic drugs"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699993675817472","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A comparative study of serum F protein and other liver function tests as an index of hepatocellular damage in epileptic patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981468408416256","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Relationship between Bone Density and Biochemical Markers of Bone among Two Groups Taking Carbamazepine and Sodium Valproate for Epilepsy in Comparison with Healthy Individuals in Yazd"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981468612616448","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Pharmacokinetic profile of levetiracetam"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981468964499584","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Toxic epidermal necrolysis with isolated neutropenia related to the use of levetiracetam"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262945491780224","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Factors That Affect the Induction of Gamma Glutamyltransferase in Epileptic Patients Receiving Anti-Convulsant Drugs"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262946364921344","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Hematologic manifestations and impaired liver synthetic function during valproate monotherapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544418603642240","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Effects of valproate on xenobiotic biotransformation in rat liver"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544419227380864","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Antiepileptic drug monotherapy versus polytherapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544419941571200","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Valproate‐induced thrombocytopenia: a prospective monotherapy study"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107369461164928","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Basic haematological parameters, serum gamma-glutamyl-transferase activity, and erythrocyte folate and serum vitamin B12 levels during carbamazepine and oxcarbazepine therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107370873060224","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Antiepileptic drugs interact with folate and vitamin B12 serum levels"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670318976518784","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Effects of Carbamazepine and Valproate on Serum Aspartate Aminotransferase, Alanine Aminotransferase and Gamma - Glutamyltransferase in Children"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670319616315648","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Levetiracetam-induced neutropenia following traumatic brain injury"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320559525632","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Induction of endogenous pathways by antiepileptics and clinical implications"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951794398610432","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Levetiracetam‐induced Thrombocytopenia"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951795275442688","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"TEGRETOL IN TRIGEMINAL NEURALGIA WITH SPECIAL REFERENCE TO HEMATOPOIETIC SIDE EFFECTS"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951796045788672","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Haematological side effects of antiepileptic drug treatment in patients with epilepsy"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233268800195840","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Effects of antiepileptic drugs on the serum folate and vitamin B12 in various epileptic patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233269631751040","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Valproate and carbamazepine comedication changes hepatic enzyme activities in sera of epileptic children"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233270331534592","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Short-term effect of levetiracetam monotherapy on haematological parameters in children with epilepsy: A prospective study"}]}],"dataSourceIdentifier":[{"@type":"JALC","@value":"oai:japanlinkcenter.org:2007167753"},{"@type":"CROSSREF","@value":"10.3805/eands.11.1"},{"@type":"CIA","@value":"130007631571"},{"@type":"KAKEN","@value":"PRODUCT-22459363"},{"@type":"OPENAIRE","@value":"doi_dedup___::aed8ceafece943179be5f0f21eebb116"}]}